Papp KA - Search Results

1

Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea.

Tan JK, Girard C, Krol A, Murray HE, Papp KA, Poulin Y, Chin DA, Jeandupeux D. Tan JK, et al. Among authors: papp ka. J Cutan Med Surg. 2002 Nov-Dec;6(6):529-34. doi: 10.1007/s10227-001-0144-4. Epub 2002 May 13. J Cutan Med Surg. 2002. PMID: 12001006 Clinical Trial.

2

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

3

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.

Bissonnette R, Papp K, Poulin Y, Lauzon G, Aspeslet L, Huizinga R, Mayo P, Foster RT, Yatscoff RW, Maksymowych WP; ISA247 Psoriasis Study Group. Bissonnette R, et al. J Am Acad Dermatol. 2006 Mar;54(3):472-8. doi: 10.1016/j.jaad.2005.10.061. Epub 2006 Jan 23. J Am Acad Dermatol. 2006. PMID: 16488299 Clinical Trial.

4

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

5

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.

Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Langley RG, et al. Among authors: papp ka. J Cutan Med Surg. 2006;9 Suppl 1:18-25. doi: 10.1007/s10227-006-0103-1. J Cutan Med Surg. 2006. PMID: 16633860 Review.

6

A favourable benefit/risk ratio with efalizumab: a review of the clinical evidence.

Poulin Y, Papp KA, Carey W, Gulliver W, Gupta AK. Poulin Y, et al. Among authors: papp ka. J Cutan Med Surg. 2006;9 Suppl 1:10-7. doi: 10.1007/s10227-006-0102-2. J Cutan Med Surg. 2006. PMID: 16633861 Review.

7

Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I.

Pariser DM, Gordon KB, Papp KA, Leonardi CL, Kwon P, Compton PG, Rundle AC, Walicke PA, Lebwohl M. Pariser DM, et al. Among authors: papp ka. J Cutan Med Surg. 2005 Dec;9(6):303-12. doi: 10.1007/s10227-005-0116-1. J Cutan Med Surg. 2005. PMID: 16699904 Review.

8

Efalizumab for the treatment of psoriatic arthritis.

Papp KA, Caro I, Leung HM, Garovoy M, Mease PJ. Papp KA, et al. J Cutan Med Surg. 2007 Mar-Apr;11(2):57-66. doi: 10.2310/7750.2007.00006. J Cutan Med Surg. 2007. PMID: 17374316 Clinical Trial.

9

A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.

Gold LS, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, Gidner J, Liu Y, Graeber M; Adapalene-BPO Study Group. Gold LS, et al. Cutis. 2009 Aug;84(2):110-6. Cutis. 2009. PMID: 19746769 Clinical Trial.

10

A Canadian self-administered online survey to evaluate the impact of moderate-to-severe psoriasis among patients.

Wasel N, Poulin Y, Andrew R, Chan D, Fraquelli E, Papp K. Wasel N, et al. J Cutan Med Surg. 2009 Nov-Dec;13(6):294-302. doi: 10.2310/7750.2009.08066. J Cutan Med Surg. 2009. PMID: 19919806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters